What about mRNA vaccines?

• Among anti-vaxers now leading HHS, CDC, FDA, and NIH, mRNA has faced added scrutiny even beyond traditional inactivated type.
• Even so, Moderna does currently have an H5 vaccine in phase 2 clinical trial, unlikely mRNA sees light of day (in US) in a pandemic.

(5/11)